United States · FDA National Drug Code directory
ELIQUIS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0003-1028_663be5ea-b58d-43c9-8138-2d9ed0846308
- Product NDC
- 0003-1028
- Form
- TABLET, FOR SUSPENSION
- Composition / generic term
- apixaban
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20250915
- Source listing expiry
- 20271231
Source-listed ingredients
- APIXABAN — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 28 PACKET in 1 CARTON (0003-1028-12) / 4 TABLET, FOR SUSPENSION in 1 PACKET · 0003-1028-12
- 28 PACKET in 1 CARTON (0003-1028-28) / 1 TABLET, FOR SUSPENSION in 1 PACKET · 0003-1028-28
- 28 PACKET in 1 CARTON (0003-1028-84) / 3 TABLET, FOR SUSPENSION in 1 PACKET · 0003-1028-84
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →